29 %Symptomatic infections accounted for 29% (644/2246) of all malaria-positive individuals.
Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
709 evidences · page 18 / 29
29 %Symptomatic infections accounted for 29% (644/2246) of all malaria-positive individuals.
Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations
30 %Among HIV-infected adults interviewed, 30% had no stable partnership.
Côte d'IvoireVIH/sidapublié 2014AIDS (London, England)europe_pmcdocument de 5 observations
13,5 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 13.5% for those who did not identify HPV as cervical cancer aetiology and 35.1% for those who did identify HPV as cervical cancer aetiology in the COVADOCY study conducted in 2025.
Côte d'Ivoireinfection à HPVobservé 2025HAL · Unilimdocument de 69 observations
3,4 %Among the 313 HIV antibodies carriers in Ivory Coast from January to December 1987, 3.4% had a double seropositivity to HIV1 and HIV2.
Côte d'IvoireHIV1 and HIV2observé 1987publié 1989PubMedOpenAlexdocument de 10 observations
8,9 %Among adolescent girls living with HIV in Côte d'Ivoire, 8.9% reported parents' refusal as a barrier to HPV vaccination.
Côte d'Ivoireinfection à HPV · VIH/sidaobservé 2024–2025HAL · Unilimdocument de 69 observations
1 %The Cameroun haplotype was detected in 1% of the samples.
Côte d'Ivoirehemoglobin disordersHAL · Unilimdocument de 23 observations
3 %The prevalence of sickle cell disease was 3% in the population analyzed.
Côte d'IvoiredrépanocytoseHAL · Unilimdocument de 23 observations
0,3 per_100_person_weeksThe mean malaria incidence was 0.30 case per 100 person-weeks.
Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations
36 %Among hospitalized HIV-positive adults in West Africa who died, tuberculosis was the most frequent fatal disease, occurring in 36% of deaths.
Côte d'Ivoiretuberculose · VIH/sidaobservé 2010publié 2014Journal of the International AIDS Societyeurope_pmcdocument de 22 observationsDOI 10.7448/ias.17.1.18797
1,24 %Mixed infection of Plasmodium falciparum and Plasmodium malariae accounted for 1.24% of identified Plasmodium species among 2246 positive blood smears.
Côte d'IvoirePlasmodium falciparum + Plasmodium malariaeHAL · Unilimdocument de 122 observations
755 participantsAt baseline, 755 participants initiated antiretroviral therapy in the Temprano randomized trial in Abidjan.
Côte d'IvoireVIH/sidapublié 2016AIDS research and therapyeurope_pmcdocument de 9 observations
43,8 %Detectable HCV RNA was identified in 43.8% of anti-HCV positive HIV-2-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobservé March to December 2012publié 2018Journal of public health in Africaeurope_pmcdocument de 9 observations
33,7 %The estimated prevalence of HIV infection among female sex workers in Abidjan, Côte d'Ivoire was 33.7%.
Côte d'IvoireVIH/sidaobservé 2013publié 2015BMC oral healtheurope_pmcdocument de 7 observations
54 %In Côte d'Ivoire, the overall prevalence of high-risk HPV in women living with HIV of childbearing age was estimated to be 54%.
Côte d'Ivoirehigh-risk HPVHAL · Unilimdocument de 69 observations
94,7 %Infection prevalence was 94.7% in Survey 2 among 860 participants.
Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations
1,66 hazard_ratioPatients aged ≥60 years had an increased risk of death in the first 36 months on ART with an adjusted hazard ratio of 1.66.
Côte d'IvoireVIH/sidapublié 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument de 7 observations
23,4 %Plasmodium falciparum was detected in 23.4% of afebrile people in Côte d'Ivoire.
Côte d'Ivoirepaludismepublié 2021Travel medicine and infectious diseasePubMeddocument de 25 observations
34,2 %Tuberculosis accounted for 34.2% of AIDS-defining reasons for hospitalization.
Côte d'Ivoiretuberculose · VIH/sidapublié 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument de 16 observations
No external and visible congenital malformation was observed in HIV-infected women exposed to efavirenz during pregnancy.
Côte d'IvoireVIH/sidaobservé 2003–2009publié 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 9 observationsDOI 10.1097/qai.0b013e3181ff04e6
8,6 per_100_person-yearsHIV incidence among regular female blood donors in Abidjan decreased from 8.6 per 100 person-years in 1992–1994 to 0.11 per 100 person-years in 2010–2012.
Côte d'IvoireVIH/sidaobservé 1992–1994publié 2018Open forum infectious diseaseseurope_pmcdocument de 12 observations
5,5 %Comorbidities were present in 5.5% of afebrile people in Côte d'Ivoire.
Côte d'Ivoirecomorbiditiespublié 2021Travel medicine and infectious diseasePubMeddocument de 25 observations
4 %HCV prevalence was 4.0% among HIV-1&2 dually reactive patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.
Côte d'Ivoirehépatite C · VIH/sidaobservé March to December 2012publié 2018Journal of public health in Africaeurope_pmcdocument de 9 observations
19,1 %The prevalence of non-obstructive carotid plaques was 19.1%.
Côte d'Ivoirenon-obstructive carotid plaquesobservé 2015publié 2021Southern African journal of infectious diseaseseurope_pmcdocument de 9 observationsDOI 10.4102/sajid.v36i1.187
1 %1% of 1,234 new samples from the Ivory Coast, Kenya, South Africa, Thailand, and the United States were identified as elite neutralizers.
Afrique du Sud · Côte d'Ivoire · KenyaVIH/sidapublié 2009Journal of virologyeurope_pmcdocument de 2 observationsDOI 10.1128/jvi.00110-09
64 %Among HIV-infected adults interviewed, 64% could not be given any recommendation regarding early initiation of antiretroviral treatment (ART) due to either no stable partnership (30%) or being in a stable partnership with an unaware partner status (34%).
Côte d'IvoireVIH/sidapublié 2014AIDS (London, England)europe_pmcdocument de 5 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.